Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hybrid material based on hyaluronan hydrogels and poly(l-lactide-co-1,3-trimethylene carbonate) scaffolds toward a cell-instructive microenvironment with long-term in vivo degradability. | Mater Today Bio | 2022 | 36407912 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression. | Front Immunol | 2022 | 36405712 | PubTator, text mining | PubMed |
| Hyaluronan nanoscale clustering and Hyaluronan synthase 2 expression are linked to the invasion of child fibroblasts and infantile fibrosarcoma in vitro and in vivo. | Sci Rep | 2022 | 36400790 | PubTator, text mining | PubMed |
| Immunotherapy for the treatment of multiple myeloma. | Front Immunol | 2022 | 36389674 | PubTator, text mining | PubMed |
| Clinical Study of the Relationship between Sjögren Syndrome and T-Cell Large Granular Lymphocytic Leukemia: Single-Center Experience. | Int J Mol Sci | 2022 | 36362126 | PubTator, text mining | PubMed |
| Rosai-Dorfman Disease between Proliferation and Neoplasia. | Cancers (Basel) | 2022 | 36358690 | PubTator, text mining | PubMed |
| Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study. | Oncotarget | 2022 | 36342462 | PubTator, text mining | PubMed |
| Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma. | Front Oncol | 2022 | 36338737 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Genetic profiling of human bone marrow mesenchymal stromal cells after in vitro expansion in clinical grade human platelet lysate. | Front Bioeng Biotechnol | 2022 | 36324892 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. | Biomed Res Int | 2022 | 36317111 | PubTator, text mining | PubMed |
| N-Cadherin adhesive ligation regulates mechanosensitive neural stem cell lineage commitment in 3D matrices. | Biomater Sci | 2022 | 36314115 | PubTator, text mining | PubMed |
| Umbilical cord mesenchymal stromal cells-from bench to bedside. | Front Cell Dev Biol | 2022 | 36313578 | PubTator, text mining | PubMed |
| Bioinformatics-based identification of miRNAs, mRNA, and regulatory signaling pathways involved in esophageal squamous cell carcinoma. | Gastroenterol Hepatol Bed Bench | 2022 | 36311956 | PubTator, text mining | PubMed |
| Significance of macrophage infiltration in the prognosis of lung adenocarcinoma patients evaluated by scRNA and bulkRNA analysis. | Front Immunol | 2022 | 36311801 | PubTator, text mining | PubMed |
Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validation. | Front Immunol | 2022 | 36311789 | PubTator, text mining | PubMed |
| VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors. | World J Gastrointest Oncol | 2022 | 36310697 | PubTator, text mining | PubMed |
| HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. | Comput Biol Med | 2022 | 36306573 | PubTator, text mining | PubMed |
| Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective Review of Molecular Advances. | Cureus | 2022 | 36299966 | PubTator, text mining | PubMed |
| Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now? | Pharmaceutics | 2022 | 36297526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=21